STOCK TITAN

ROIV (NASDAQ: ROIV) proposes sale of 70,000 shares via option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ROIV files a Form 144 proposing the sale of 70,000 common shares. The notice states the shares arise from an exercise of options under a registered plan and are to be sold through Morgan Stanley Smith Barney LLC on 03/26/2026. The filing lists proceeds of $1,921,458.00 and a reference number 715,701,137 on the form.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 notice for exercised options and proposed sale of shares.

The filing lists $1,921,458.00 tied to the proposed sale of 70,000 common shares via Morgan Stanley Smith Barney LLC on 03/26/2026. The transaction is described as an exercise of options under a registered plan.

Under Rule 144 practice, this form notifies the market of an intended resale; the ultimate sale depends on market execution and any applicable volume or holding-period constraints. Subsequent transaction reports will confirm completion and exact cash flows.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Roivant Sciences

NASDAQ:ROIV

View ROIV Stock Overview

ROIV Rankings

ROIV Latest News

ROIV Latest SEC Filings

ROIV Stock Data

19.57B
517.69M
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
LONDON